Article info

Download PDFPDF

Extended report
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study

Authors

  1. Correspondence to Professor Bernard Combe, Departement de Rhumatologie, Hôpital Lapeyronie, Université Montpellier I, Montpellier UMR 5535, France; b-combe{at}chu-montpellier.fr
View Full Text

Citation

Combe B, Dasgupta B, Louw I, et al
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study

Publication history

  • Accepted May 2, 2013
  • First published June 5, 2013.
Online issue publication 
July 03, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.